Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$173M |
| 2 |
Amcor
AMCR
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$99.3M |
| 4 |
Amazon
AMZN
|
+$97.5M |
| 5 |
Intel
INTC
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$126M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$123M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$58.6M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$45.7M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.86% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 12.78% |
| 4 | Industrials | 10.5% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Aldeyra Therapeutics
ALDX
$91.1M
| $370K | ﹤0.01% |
61,536
+19,826
| +48% | +$149K |
|
2952
Celcuity
CELC
$4.43B
| $368K | ﹤0.01% |
14,709
+1,309
| +10% | +$28.8K |
|
|
UBFO
2953
DELISTED
United Security Bancshares
UBFO
| $368K | ﹤0.01% |
32,297
+2,274
| +8% | +$23.8K |
|
|
MTEM
2954
DELISTED
Molecular Templates, Inc.
MTEM
| $366K | ﹤0.01% |
2,919
+658
| +29% | +$71.5K |
|
2955
First Northwest Bancorp
FNWB
$105M
| $363K | ﹤0.01% |
22,326
| – | – |
|
|
AFMD
2956
DELISTED
Affimed
AFMD
| $360K | ﹤0.01% |
+12,539
| New | +$422K |
|
2957
Hawthorn Bancshares
HWBK
$275M
| $360K | ﹤0.01% |
+15,709
| New | +$330K |
|
2958
Twin Disc
TWIN
$342M
| $360K | ﹤0.01% |
23,813
+1,948
| +9% | +$30.3K |
|
|
JAX
2959
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $360K | ﹤0.01% |
32,056
-32,568
| -50% | -$350K |
|
2960
Clearfield
CLFD
$391M
| $359K | ﹤0.01% |
27,093
| – | – |
|
2961
Pulse Biosciences
PLSE
$2.96B
| $357K | ﹤0.01% |
26,993
+1,853
| +7% | +$25.3K |
|
2962
Anavex Life Sciences
AVXL
$314M
| $355K | ﹤0.01% |
105,179
+89,305
| +563% | +$277K |
|
|
HZN
2963
DELISTED
Horizon Global Corporation
HZN
| $354K | ﹤0.01% |
98,518
-18,799
| -16% | -$61.3K |
|
|
KLDO
2964
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $353K | ﹤0.01% |
+30,389
| New | +$443K |
|
|
ESSA
2965
DELISTED
ESSA Bancorp
ESSA
| $352K | ﹤0.01% |
23,047
+1,606
| +7% | +$24.7K |
|
2966
Neuronetics
STIM
$151M
| $352K | ﹤0.01% |
28,082
+443
| +2% | +$6.26K |
|
|
MFNC
2967
DELISTED
Mackinac Financial Corporation
MFNC
| $350K | ﹤0.01% |
+22,090
| New | +$349K |
|
|
TCRR
2968
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $349K | ﹤0.01% |
+24,364
| New | +$389K |
|
2969
Union Bankshares
UNB
$109M
| $348K | ﹤0.01% |
9,399
+699
| +8% | +$26.3K |
|
2970
GSI Technology
GSIT
$255M
| $345K | ﹤0.01% |
+40,226
| New | +$324K |
|
|
MRSN
2971
DELISTED
Mersana Therapeutics
MRSN
| $345K | ﹤0.01% |
3,402
+2,008
| +144% | +$237K |
|
|
DLA
2972
DELISTED
Delta Apparel Inc.
DLA
| $342K | ﹤0.01% |
+14,729
| New | +$335K |
|
|
BRT
2973
BRT Apartments
BRT
$266M
| $341K | ﹤0.01% |
24,100
+1,897
| +9% | +$25.9K |
|
2974
Forte Biosciences
FBRX
$1.57B
| $341K | ﹤0.01% |
136
+10
| +8% | +$29.7K |
|
|
ITI
2975
DELISTED
Iteris, Inc.
ITI
| $341K | ﹤0.01% |
65,956
+11,905
| +22% | +$57.1K |
|
Similar funds
Charles Schwab's Q2 2019 Portfolio in Review
As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
- Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
- Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
- Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
- Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
- Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
- Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.